Digital Health
XpertDox Closes Latest Round of Funding
XpertDox, a software company specializing in autonomous medical coding powered by artificial intelligence, announced the closing of their latest round…
XpertDox, a software company specializing in autonomous medical coding powered by artificial intelligence, announced the closing of their latest round of funding. XpertDox’s XpertCoding solution harnesses the power of artificial intelligence in order to autonomously code medical claims faster, more accurately, and cheaper than traditional manual processes. This round was highlighted by investment from the leadership of TN3, LLC, an Arizona based Private Equity Capital firm.
XpertDox was founded in 2015 by two physicians in Birmingham, Alabama on a mission to improve access to clinical trials. XpertDox’s first product, XpertTrial, is a clinical trials database management, search engine, and patient recruitment platform custom-built for healthcare organizations to recruit patients. More recently, XpertDox has launched XpertCoding, an autonomous coding solution that harnesses the power of artificial intelligence to accelerate the revenue cycle so you can get back to focusing on providing great healthcare.
Recommended AI News: Splunk and JupiterOne Partner to Provide Deeper Visibility into Cloud Asset Data and Increase the Accuracy of Threat Detection and Response
XpertDox has been headquartered in Birmingham, Alabama for the entirety of its existence. However, the success of its XpertCoding solution has garnered attention from around the country. TN3, LLC, recently participated in XpertDox’s latest round of funding.
“We’re excited about partnering with the XpertDox Team,” said Mike Pierce, TN3’s Managing Partner. “Their technology and products offer significant advantages to their clients for Coding and Clinical Trials and we’re confident that the Company with have both short and long-term success.”
Recommended AI News: Videotron Partners With EMnify to Power New Enterprise IoT Connectivity Offering
TN3, LLC is an Arizona based private equity firm led by Mike Pierce and Chuck Ensign. Both bring a broad array of successful entrepreneurial, acquisition, business, and technology development experience to their investment partners. TN3’s Investment in XpertDox represents the firm’s first investment in a company headquartered in the state of Alabama.
XpertDox is utilizing the funding to scale their marketing and sales efforts as well as expanding their programming infrastructure.
Recommended AI News: Nielsen’s Gracenote Quantifies Program Bingeability, Tracks Streaming Availability Through New Content Analytics Datasets
[To share your insights with us, please write to sghosh@martechseries.com]
The post XpertDox Closes Latest Round of Funding appeared first on AiThority.
artificial intelligence
ai
iot
software
healthcare
medical
private equity
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…